MassDevice

MassDevice.com offers news and insights specifically for the medical device sector and the businesses behind it. Known as a trusted resource in the med-tech field, MassDevice.com delivers high-quality, original news coverage. Each month, it attracts over 100,000 readers via its main website and email newsletters.

National, Trade/B2B

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#455367

United States

#171296

Health/Health

#3298

Traffic sources

Monthly visitors

Articles

GE HealthCare, Raydiant Oximetry partner on fetal pulse oximetry

1 day ago | massdevice.com | Sean Whooley

GE HealthCare (Nasdaq: GEHC) announced a joint development initiative with Raydiant Oximetry to enhance fetal monitoring capabilities.
AdvaMed calls for medtech tariff exemptions at Senate hearing

1 day ago | massdevice.com | Chris Newmarker

AdvaMed CEO Scott Whitaker appeared before the U.S. Senate Finance Committee today to continue to assert that medtech deserves tariff exemptions in trade negotiations. “To be clear, we applaud the president’s efforts to bring more manufacturing back the United States and fix some of the existing trade imbalances, but the reality is, up to 70% of medtech used in America is already made in America, supporting 3 million jobs across this country, and that’s growing every day.
BD files patent infringement lawsuit against Baxter over infusion pump tech

2 days ago | massdevice.com | Sean Whooley

BD (NYSE:BDX) has alleged patent infringement by Baxter (NYSE:BAX) in a new legal complaint related to infusion pump technology. Our sister site, Drug Delivery Business News, reports today that BD filed its complaint in the U.S. District Court for the District of Delaware on May 12, 2025, alleging the “infringing manufacture, use, importation, offer for sale, and/or sale” of the Novum IQ infusion system by Baxter. BD and its CareFusion subsidiary provide the Alaris infusion platform.
Apreo Health emerges from stealth with positive data for lung scaffold

2 days ago | massdevice.com | Sean Whooley

Apreo Health today announced its emergence from stealth and an upcoming presentation of first-in-human clinical data for its emphysema treatment. Menlo Park, California-based Apreo develops the Breathe airway scaffold. It designed the first-of-its-kind implant to relieve pressure in overinflated lungs without removing or sacrificing healthy tissue. The company says traditional interventions have limitations and carry significant complication rates.
Tivic adds new vagus nerve stim patent

2 days ago | massdevice.com | Carrie Pallardy

Tivic Health Systems (Nasdaq:TIVC) filed a patent application for its vagus nerve stimulation (VNS) system. Tivic has a portfolio of patients for its non-invasive VNS technology, and it aims to expand it with this new application. In July 2024, the health tech company added three patents granted in the U.S. and Europe, further shoring up its intellectual property portfolio.
Study backs Teleflex stapler for reducing post-op GERD rates

2 days ago | massdevice.com | Carrie Pallardy

Teleflex (NYSE: TFX) announced the results of a study comparing the use of its Titan SGS Stapler with traditional multi-fire surgical staplers. The retrospective analysis found that the Titan SGS Stapler is associated with lower rates of postoperative GERD and shorter-than-average lengths of stay in the hospital following sleeve gastrectomy. Previous research reveals that worsening or de novo GERD is a concern following this common weight loss procedure.
Paragonix LiverGuard enables a cross-country liver transplant

2 days ago | massdevice.com | Chris Newmarker

Paragonix Technologies announced today that its LiverGuard System successfully preserved a donor liver transported from the West Coast to a transplant performed at Duke University Hospital in North Carolina. Waltham, Massachusetts–based Paragonix, which Swedish medtech company Getinge acquired for $477 million in 2024, said the case marks one of the longest liver procurements on record, utilizing the company’s advanced hypothermic preservation.
Imperative Care completes enrollment in pulmonary embolism study

2 days ago | massdevice.com | Sean Whooley

Imperative Care announced today that it completed enrollment in the SYMPHONY-PE pivotal investigational device exemption (IDE) study. The FDA IDE study evaluates the company’s Symphony Thrombectomy System for treating acute pulmonary embolism (PE). Designed to expand Symphony’s current indication for use to include PE, investigators conducted the study across 19 U.S. centers. Imperative Care designed Symphony to deliver consistent, seamless clot removal in one fully integrated solution.
Dexcom promotes Jake Leach to president role

2 days ago | massdevice.com | Sean Whooley

Dexcom (Nasdaq: DXCM) DexCom, Inc. Open 86.674 Day High 86.674 52 Week High 142 52 Week Low 62.34 today announced a significant internal promotion for a longtime member of its leadership team. Our sister site, Drug Delivery Business News, reports today that Jake Leach, the company’s COO, received a promotion to the post of president, too. Leach, who has spent 21 years at Dexcom, originally took over as COO in 2022.
Synchron announces BCI integration with Apple tech

2 days ago | massdevice.com | Sean Whooley

Synchron announced today that it will become the first brain-computer interface (BCI) maker to achieve native integration with a new Apple protocol. Apple today unveiled its BCI Human Interface Device (BCI HID) profile, enabling the recognition of neural interfaces as a native input category, coming to Apple devices. Users implanted with Synchron’s BCI can control an iPhone, iPad and Apple Vision Pro directly with their thoughts. It requires no physical movement or voice commands.